Healthcare Services company Inventurus Knowledge Solutions announced Q4FY25 & FY25 results Q4FY25 Financial Highlights: Revenue growth in Q4, 17% YoY in INR, 13% YoY in USD Q4 EBITDA up 68% YoY; 13% QoQ PAT up 133% growth YoY; 14% QoQ Adjusted PAT up 108% YoY; 13% QoQ Revenue: 7,240 million PAT: Rs 1,478 million EBITDA: Rs 2,262 million Adjusted PAT: Rs 1,646 million FY25 Financial Highlights: Revenue at Rs 26,640 million (47% YoY) EBITDA at Rs 7,911 million (50% YoY) PAT at Rs 4,861 million (31% YoY) Adjusted PAT at Rs 5,504 (39% YoY) Sachin K. Gupta, Founder & CEO, IKS Health. said, “The results for the quarter reflect the strength of our business where we have delivered industry leading revenue growth owing to ramp up of new clients and continuous margin improvement as we continue to transform the business using technology and global human capital. Our Q4FY25 EBITDA margins have crossed 31%, a significant improvement from the 24% proforma margin of FY24,” “The last quarter saw five prominent client wins including three platform deals which gives us the confidence in our strategy of building the full breadth of our platform in a market that largely consists of point solutions companies.” Nithya Balasubramanian, CFO, IKS Health said, “We have delivered a very healthy margin and strong revenue growth of 17% YoY and 10% QoQ despite some compression in revenue as we focus on the right set of customers and globalize the legacy AQuity workforce. Ongoing investments in technology and AI will remain central to our strategy for achieving excellence in outcomes and client satisfaction.” Result PDF
Conference Call with Inventurus Knowledge Solutions Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.
Healthcare Services company Inventurus Knowledge Solutions announced Q3FY25 results Revenue at Rs 6,572 million (15.9% YoY / + 2.2% QoQ growth). EBITDA at Rs 2,006 million at 30.5% of revenue (24.3% YoY / +5.7% QoQ growth). PAT at Rs 1,297 million at 19.7% of revenue (27.7% YoY / 14.8% QoQ growth). Adjusted PAT at Rs 1,455 million at 22.1% of revenue (30.6% YoY / 12.8% QoQ growth). Sachin K. Gupta, Founder and Chief Executive Officer, IKS Health, said: “We continue our journey of improving profitability by transforming legacy AQuity’s operating model through technology and global human capital. EBITDA margins have crossed 30% this quarter, a significant improvement from the 24% proforma margin of FY24. With revenue from our top five customers growing 19% and new client acquisitions ramping up, we are optimistic about sustained growth heading into the final quarter and the next financial year.” Nithya Balasubramanian, Chief Financial Officer, IKS Health, said: “We are steadily regaining our legacy IKS EBITDA margins. PAT growth has outpaced EBITDA growth due to lower finance costs as we continue to repay our debt. Adjusted PAT, excluding non-cash amortization of acquired intangibles, has improved by 31%. We will maintain our investments in technology and AI to drive superior outcomes and enhance customer satisfaction.” Result PDF
Conference Call with Inventurus Knowledge Solutions Management and Analysts on Q3FY25 Performance and Outlook. Listen to the full earnings transcript.